☆ 4.4 Editorial Material

Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Volume 33, Issue 8, Pages 853-855

Publisher

CAMBRIDGE UNIV PRESS

DOI: 10.1086/666632

Keywords

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Publisher

CAMBRIDGE UNIV PRESS

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Extended-Spectrum β-Lactamase Producers Reported as Susceptible to Piperacillin-Tazobactam, Cefepime, and Cefuroxime in the Era of Lowered Breakpoints and No Confirmatory Tests

Journal

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Publisher

CAMBRIDGE UNIV PRESS

Keywords

Categories

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper